Annual Report

Overview

The report highlights Krka Group sales of EUR 1,191.6 million and 10,499 employees. It reports authorizations for 19 new products in 47 dosage forms and strengths. The Notol 2 plant, the Group's largest investment, was completed, with trial production expected to start in early 2015 and annual capacity of 4.5 billion tablets and capsules.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2014
Period: Ends 31 December 2014
Publication date: 25 March 2015
Language: English
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services